MEDNAX (MD) Tops Q4 EPS by 4c, Beats on Revenues; 1Q18 EPS Guidance Above Consensus

MEDNAX (NYSE: MD) reported Q4 EPS of $0.87, $0.04 better than the analyst estimate of $0.83. Revenue for the quarter came in at $911 million versus the consensus estimate of $885.08 million.

• On a non-GAAP basis, which excludes this benefit, Adjusted EPS of $0.87
• Net revenue of $911 million;
• Net income of $136 million; and
• EBITDA of $155 million

2018 First Quarter Outlook

For the 2018 first quarter, MEDNAX expects earnings per share will be in a range of $0.63 to $0.68 per diluted share and Adjusted EPS will be in a range of $0.84 to $0.89. The Adjusted EPS range excludes $0.13 per diluted share of estimated amortization expense and $0.08 per diluted share of estimated stock-based compensation expense.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance
• Oil-Dri raises dividend for 23rd consecutive year, authorizes buybacks
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance